Eledon Pharmaceuticals, Inc. (ELDN)
NASDAQ: ELDN · Real-Time Price · USD
2.850
-0.050 (-1.72%)
May 14, 2025, 9:57 AM - Market open
Eledon Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 20.55 | 4.61 | 56.41 | 84.83 | 114.2 | Upgrade
|
| Short-Term Investments | 119.63 | 46.49 | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 140.18 | 51.1 | 56.41 | 84.83 | 114.2 | Upgrade
|
| Cash Growth | 174.31% | -9.41% | -33.51% | -25.71% | 1199.00% | Upgrade
|
| Other Receivables | - | - | - | - | 0.11 | Upgrade
|
| Receivables | - | - | - | - | 0.11 | Upgrade
|
| Prepaid Expenses | 2.82 | 4.94 | 3.08 | 3.48 | 1.29 | Upgrade
|
| Other Current Assets | 0.73 | 0.09 | 0.03 | 0.03 | 0.04 | Upgrade
|
| Total Current Assets | 143.73 | 56.13 | 59.52 | 88.35 | 115.63 | Upgrade
|
| Property, Plant & Equipment | 0.93 | 0.37 | 0.74 | 0.77 | 0.14 | Upgrade
|
| Goodwill | - | - | - | 48.65 | 48.65 | Upgrade
|
| Other Intangible Assets | 32.39 | 32.39 | 32.39 | 32.39 | 32.39 | Upgrade
|
| Other Long-Term Assets | 0.36 | 0.19 | 0.15 | 0.4 | 0.38 | Upgrade
|
| Total Assets | 177.41 | 89.07 | 92.79 | 170.55 | 197.19 | Upgrade
|
| Accounts Payable | 5.83 | 0.97 | 2.2 | 1.81 | 1.37 | Upgrade
|
| Accrued Expenses | 5.43 | 2.55 | 3.91 | 2.22 | 0.97 | Upgrade
|
| Current Portion of Leases | 0.31 | 0.38 | 0.36 | 0.37 | 0.14 | Upgrade
|
| Total Current Liabilities | 11.58 | 3.9 | 6.48 | 4.4 | 2.48 | Upgrade
|
| Long-Term Leases | 0.64 | - | 0.38 | 0.4 | - | Upgrade
|
| Long-Term Deferred Tax Liabilities | 2.18 | 1.75 | 1.75 | 1.75 | 4.11 | Upgrade
|
| Other Long-Term Liabilities | 44.87 | 76.21 | - | - | - | Upgrade
|
| Total Liabilities | 59.27 | 81.86 | 8.61 | 6.55 | 6.59 | Upgrade
|
| Common Stock | 0.06 | 0.02 | 0.01 | 0.01 | 0.02 | Upgrade
|
| Additional Paid-In Capital | 473.64 | 326.59 | 287.03 | 278.88 | 270.97 | Upgrade
|
| Retained Earnings | -355.59 | -319.4 | -202.87 | -114.9 | -80.39 | Upgrade
|
| Comprehensive Income & Other | 0.03 | - | - | - | - | Upgrade
|
| Total Common Equity | 118.14 | 7.21 | 84.18 | 164 | 190.6 | Upgrade
|
| Shareholders' Equity | 118.14 | 7.21 | 84.18 | 164 | 190.6 | Upgrade
|
| Total Liabilities & Equity | 177.41 | 89.07 | 92.79 | 170.55 | 197.19 | Upgrade
|
| Total Debt | 0.95 | 0.38 | 0.75 | 0.77 | 0.14 | Upgrade
|
| Net Cash (Debt) | 139.22 | 50.72 | 55.66 | 84.06 | 114.05 | Upgrade
|
| Net Cash Growth | 174.50% | -8.88% | -33.78% | -26.29% | 1247.01% | Upgrade
|
| Net Cash Per Share | 2.87 | 2.06 | 3.90 | 5.67 | 78.58 | Upgrade
|
| Filing Date Shares Outstanding | 59.88 | 24.81 | 13.78 | 14.31 | 14.31 | Upgrade
|
| Total Common Shares Outstanding | 59.79 | 24.21 | 13.78 | 14.31 | 15.16 | Upgrade
|
| Working Capital | 132.15 | 52.23 | 53.04 | 83.95 | 113.15 | Upgrade
|
| Book Value Per Share | 1.98 | 0.30 | 6.11 | 11.46 | 12.57 | Upgrade
|
| Tangible Book Value | 85.75 | -25.18 | 51.8 | 82.96 | 109.56 | Upgrade
|
| Tangible Book Value Per Share | 1.43 | -1.04 | 3.76 | 5.80 | 7.23 | Upgrade
|
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.